Merck KGaA
MKKGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $48 | $48 | $55 | $60 |
| - Cash | $2 | $1 | $1 | $2 |
| + Debt | $0 | $0 | $0 | $10 |
| Enterprise Value | $46 | $47 | $54 | $68 |
| Revenue | $5 | $5 | $5 | $5 |
| % Growth | 1.2% | -0.5% | -2.5% | – |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 60.4% | 57.6% | 59.6% | 57.2% |
| EBITDA | $2 | $1 | $2 | $1 |
| % Margin | 32.1% | 26% | 28.5% | 26.2% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 17% | 12.4% | 13.9% | 12.3% |
| EPS Diluted | 0.41 | 0.3 | 0.34 | 0.31 |
| % Growth | 36.7% | -11.8% | 9.7% | – |
| Operating Cash Flow | $2 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | $1 | $0 | $0 | $1 |